Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of GLUE will rise by +7.49% over the next 2 Weeks and hit $25.69 by Monday, July 13, 2026. In that time frame, GLUE's share price is expected to range between $24.53 and $26.77.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 13, 2026 | 24.53 | 25.69 | 26.77 |
| Jul 10, 2026 | 23.86 | 25.00 | 26.13 |
| Jul 9, 2026 | 23.93 | 25.12 | 26.21 |
| Jul 8, 2026 | 23.73 | 24.79 | 25.77 |
| Jul 7, 2026 | 23.41 | 24.44 | 25.52 |
| Jul 6, 2026 | 23.46 | 24.57 | 25.64 |
| Jul 3, 2026 | 22.76 | 23.88 | 24.87 |
| Jul 2, 2026 | 22.86 | 24.00 | 25.13 |
| Jul 1, 2026 | 22.64 | 23.67 | 24.74 |
| Jun 30, 2026 | 22.16 | 23.32 | 24.43 |
GLUE shares rose +1.26% in Tuesday, June 30, 2026's trading session, rising from a previous close of $23.90 to move at $24.20. The stock demonstrated notable intraday movement (see GLUE's key stats for a full breakdown), fluctuating between $23.46 and $24.75, a +5.49% trading range. While recent weeks have seen some volatility, GLUE has managed to secure a +36.26% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.33M shares changing hands, 496.21K more than the previous session. This amounted to $56.49M in total market activity.
Will GLUE Continue Its Upward Trend?
According to analyst ratings and projections for GLUE, Monte Rosa Therapeutics, Inc. shares are anticipated to increase by +9.60%, potentially reaching $26.77 per share by July 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for GLUE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the GLUE stock forecast, now is a good time to buy GLUE stock because its current trading price is -5.80% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on GLUE covering social and institutional perspectives.
GLUE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into GLUE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 72.04% to 86.34%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 61.11%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 58.10%, maintains a neutral outlook for the long term. Insights into GLUE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Monte Rosa Therapeutics Short-Term Forecasts
GLUE Forecast For Next 5 Days
Our algorithm anticipates Monte Rosa Therapeutics (GLUE) stock could hit $24.64 by Jul 07, 2026. This represents a +1.82% rise from today's price, following a +3.04% change over the past five days.
GLUE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Monte Rosa Therapeutics, Inc. (GLUE) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $24.84, which would mean a +2.64% increase from the current price of $24.20. Projections for this period range from a high of $28.28 to a low of $21.88.
GLUE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Monte Rosa Therapeutics's price over the next three months point to a drop. GLUE stock is expected to peak at $26.89 on Sep 23, 2026 after potentially dipping to $21.52 on Jul 07, 2026. On average, GLUE is likely to trade around $24.03 in the coming 90 days.
Monte Rosa Therapeutics Stock Forecast 2025
Based on our predictive models, Monte Rosa Therapeutics (GLUE) is expected to trade between $21.52 and $29.80 throughout 2026. This would result in an average price of $24.62, potentially offering investors a +1.74% return from current levels.
Monte Rosa Therapeutics, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Monte Rosa Therapeutics, Inc. (GLUE) is positioned to show a strong performance in July 2026. The price is predicted to move between $21.52 and $26.04, settling at an average of $23.56. This could translate to a -2.64% loss.
August 2026
Based on current market signals, Monte Rosa Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $21.65 to $25.72, with a likely average price of $23.80. Investors could expect a potential return of -1.65%.
September 2026
Our predictive algorithms indicate Monte Rosa Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $22.35–$26.89, with an average target of $24.74. This represents a positive outlook and a possible gain of +2.23%.
October 2026
Analyzing established trends, Monte Rosa Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $22.03 and $27.05, averaging around $24.81. This suggests a +2.52% gain from current levels.
November 2026
Market indicators suggest Monte Rosa Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $23.31 to $29.80, with a midpoint forecast of $25.81. The stock might deliver a +6.65% gain.
December 2026
Forecasting for December 2026, models estimate that Monte Rosa Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $23.01 and $27.33, averaging $25.07. This signals a positive trajectory with potential returns around +3.60%.
January 2027
According to our latest forecast models, Monte Rosa Therapeutics, Inc. (GLUE) is positioned to show a strong performance in January 2027. The price is predicted to move between $23.33 and $27.28, settling at an average of $25.38. This could translate to a +4.88% gain.
February 2027
Based on current market signals, Monte Rosa Therapeutics, Inc. is projected to trend february 2027. We forecast a trading range from $24.18 to $28.37, with a likely average price of $26.33. Investors could expect a potential return of +8.80%.
March 2027
Our predictive algorithms indicate Monte Rosa Therapeutics, Inc. stock may see a shift in March 2027. The expected range spans $24.20–$28.43, with an average target of $26.40. This represents a positive outlook and a possible gain of +9.09%.
April 2027
Analyzing established trends, Monte Rosa Therapeutics, Inc. looks set to move in April 2027. Projections place the stock between $24.75 and $29.60, averaging around $27.14. This suggests a +12.15% gain from current levels.
May 2027
Market indicators suggest Monte Rosa Therapeutics, Inc. could experience notable changes during May 2027. Prices could fluctuate within $24.59 to $28.85, with a midpoint forecast of $26.64. The stock might deliver a +10.08% gain.
June 2027
Forecasting for June 2027, models estimate that Monte Rosa Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $24.94 and $28.78, averaging $26.90. This signals a positive trajectory with potential returns around +11.16%.
GLUE's history of dividends and stock splits also plays a role in long-term investor confidence.